Protective effect of aminoguanidine, a nitric oxide synthase inhibitor, against carbon tetrachloride induced hepatotoxicity in mice

Life Sciences

Volumn 66, Issue 3, 1999, Pages 265-270

  Al Shabanah, Othman A ^a   Alam, Khurshid ^a   Nagi, Mahmoud N ^a   Al Rikabi, Ammar C ^b   Al Bekairi, Abdullah M ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Aminoguanidine; Carbon tetrachloride; Hepatotoxicity; Nitric oxide

Indexed keywords

AMINOGUANIDINE; AMINOTRANSFERASE; CARBON TETRACHLORIDE; ENZYME INHIBITOR; LIPID PEROXIDASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; ENZYME INHIBITION; ENZYME INHIBITOR INTERACTION; LIPID PEROXIDATION; LIVER NECROSIS; LIVER PROTECTION; LIVER TOXICITY; MALE; MOUSE; NONHUMAN;

EID: 0033544642     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(99)00589-5     Document Type: Article

References (24)

1. 1. R.O. Recknagel, E.A. Glende, J.A. Dolak, and R.L. Waller, Pharmacol. Therapeutics. 43 139-154 (1989).
2. 2. P.B. McCay, E.K. Lai, J.L. Poyer, C.M. Dubose, and E.G. Janzen, J. Biol. Chem. 259 2135-2143 (1984).
3. 3. T.F. Slater, Biochem. J. 222 1-15 (1984).
4. 4. T.F. Slater, B.C. Sawyer, J. Biochem. 123 815-821 (1971).
5. 5. D.L. Laskin, del Valle M. Rodriguez, D.E. Heck, S.M. Hwang, S.T. Ohnishi, S.K. Durham, and N.L. Goller, Hepatology. 22 223-234 (1995).
6. 6. C. Thiemermann, H. Ruetten, C.C. Wu, and J.R. Vane, Br. J. Pharmacol. 116 2845-2851 (1995).
7. 7. S.S. Gross, M.S. Wolin, Annu. Rev Physiol. 57 737-769 (1995).
8. 8. W. Chamulitrat, M.E. Blazka, S.J. Jordan, M.I. Luster, and R.P. Mason, Life Sci. 24 2273-2280 (1995).
9. 9. H. Ischiropoulos, L. Zhu, J.S. Beckman, Arch. Biochem. Biophys. 298 446-451 (1992).
10. 10. R. Radi, J.S. Bechman, K.M. Bush, and B. Freeman, J. Biol. Chem. 266 4244-4250 (1991).
11. 11. H. Ischiropoulos, L. Zhu, J. Chen, M. Tsai, J.C. Martin, C.D. Smith, and J.S. Beckman, Arch. Biochem. Biophys. 298 431-437 (1992).
12. 12. T.P. Misko, W.M. Moore, T.P. Kasten, G.A. Nickols, J.A. Corbett, R.G. Tilton, M.L. McDaniel, J.R. Williamson, and M.G. Currie, Eur. J. Pharmacol. 233 119-125 (1993).
13. 13. K. Aoki, M. Ohmori, M. Takimoto, H. Ota, and T. Yoshida, Eur. J. Pharmacol. 336 43-49 (1997).
14. 14. C.R. Gardner, D.E. Heck, C.S. Yang, P.E. Thomas, X.J. Zhang, G.L. Degeorge, J.D. Laskin, and D.L. Laskin, Hepatology. 27 748-754 (1998).
15. 15. C. Diez-Fernandez, N. Sanz, A.M. Alvarez, A. Zaragoza, and M. Cascales, British J. Pharmacol. 125 102-108 (1998).
16. 16. S.U. Bergmeyer, H. Buttner, G. Hillman, Zeitschriff Klinische Chem. Biochem. 10 281-288 (1972 ).
17. 17. M. Uchiyama, M. Mihara, Anal. Biochem. 86 271-278 (1978).
18. 18. P.J. Houghton, R. Zarka, B. DeLas Heras, and J.R.S. Hoult, Planta Med. 61 33-36 (1995).
19. 19. K. Alam, M.N. Nagi, O.A. Badary, O.A. Al-Shabanah, A.C. Al-Rikabi, and A.M. Al-Bekairi, Pharmacol. Res. (1999). In press
20. 20. S. Moncada, A. Higgs, N. Engl. J. Med. 329 2002-2012 (1993).
21. 21. D.L. Laskin, D.E. Heck, C.R. Gardner, L.S. Feder, and J.D. Laskin, J. Leukoc. Biol. 56 751-758 (1994).
22. 22. L. Helyar, D.S. Bundschuh, J.D. Laskin, and D.L. Laskin, Hepatology. 20 1509-1515 (1994).
23. 23. M. Shiomi, Y. Wakabayash, T. Sano, Y. Shinoda, Y. Nimura, Y. I Shimura, and M. Suematsu, Hepatology. 27 108-115 (1998).
24. 24. C. Szabo, G. Ferrer-Sueta, B. Zingarelli, G.J. Southan, A.L. Salman, and R. Radi, J. Biol. Chem. 272 9030-9036 (1997).